初级胆道胆管炎的基于机制的向治疗:肝硬化之前的机会?
Yushu Yang1, XiaoSong He2, Manuel Rojas2,3
1Department of Rheumatology and Immunology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Frontiers in immunology
|June 16, 2023
概括
初级胆道胆炎 (PBC) 是一种复杂的肝脏疾病. 针对其免疫和纤维化途径的新疗法显示出减缓进展的希望,解决目前治疗方法的局限性.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 初级胆道胆炎 (PBC) 是一种免疫媒介的肝脏疾病,导致胆,纤维化和潜在的肝硬化.
- 目前的治疗方法,如乌尔索多胆酸 (UDCA) 和肥胆酸 (OCA),对许多患者的疗效有限.
- 了解PBC病原体对于开发有效疗法至关重要.
研究的目的:
- 审查关于PBC免疫和细胞机制的当前知识.
- 讨论PBC目前基于机制的治疗方法.
- 探索改善现有治疗疗效的潜在策略.
主要方法:
- 关于PBC病变发生的最新研究的文献综述.
- 对PBC目前和管道中药物开发的分析.
- 综合有关PBC免疫,细胞和纤维细胞路径的信息.
主要成果:
- 针对特定病原体检查点的新药开发显示出有前途.
- 正在开发针对免疫失调,胆固醇和纤维化的疗法.
- 有需要的治疗方法,可以停止疾病的进展,以肝硬化和肝衰竭.
结论:
- 了解PBC病变的重大进展有助于开发新药.
- 专注于免疫调节,抗炎症,抗胆固醇化和抗纤维化的向治疗正在出现.
- 进一步的研究是必要的,以确定可以有效地阻碍PBC进展的治疗方法.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Chronic Bowel Disorders: Introduction
492
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
492
Chronic Pancreatitis II: Collaborative Care
116
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
116
Targets for Drug Action: Overview
6.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.5K


